Insider filing · AXGN
Michael D Dale
Chief Executive Officer
profile →
Axogen, Inc.
AXGN · Healthcare · 30 filings in 24 months
ticker →
Michael D Dale sold $1.9M of Axogen (AXGN)
Executed Dec 9 2025, disclosed Dec 10 2025, 1 day later.
Value, as filed
$1.9M
61,463 sh × $31.21
Executed
Dec 9 2025
the trade date, as filed
Disclosed
Dec 10 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MDMichael D Dale (Chief Executive Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Axogen, Inc. (AXGN). The largest single filing was $1.9M of AXGN (61,463 sh × $31.21, as filed), executed Dec 9 2025.
The name
AXGNHealthcare · Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerv…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Michael D Dale in AXGN
AXGNSALE
Axogen, Inc.
$750K25,000 sh × $30.00
Exec Dec 10 2025
Filed Dec 12 2025 · 5:30 PM ET